Category: Defective Drugs
Court Docs Shed Light on Tylenol Lobbying Campaign
October 13, 2015 — Court documents have shed light on a previously-undisclosed lobbying campaign aimed at preventing the FDA from imposing strict safety regulations on over-the-counter Tylenol. ProPublica reports that executives at McNeil Consumer HealthCare, led by company president Peter...
Judges Deny 2nd Motion to Centralize Cymbalta Lawsuits
October 12, 2015 — For the second time in less than a year, federal judges have decided not to centralize dozens of lawsuits involving withdrawal side effects of Cymbalta. Back in August 2014, plaintiffs asked the Judicial Panel on Multi-district...
Invokana Linked to Higher Risk of Ketoacidosis
Invokana increases the risk of Diabetic Ketoacidosis (DKA) compared to other types of diabetes drugs.
Judges May Centralize Growing Number of Zofran Lawsuits
October 1, 2015 — The U.S. Judicial Panel on Multi-district Litigation (JPML) meets today to decide whether to centralize lawsuits involving birth defects from the anti-nausea drug Zofran. The cases are scheduled for oral argument during a hearing in Manhattan....
Mississippi Mom Files Zofran Cleft Palate Lawsuit
September 18, 2015 — A growing number of lawsuits have been filed by parents of babies with cleft palate, a serious birth defect linked to the use of Zofran during pregnancy. The federal lawsuit (PDF) -- Case No. 5:15-cv-00070 --...
Another 500 Lipitor Diabetes Lawsuits Filed this Summer
September 18, 2015 — Federal judges have released updated statistics (PDF) reporting that 2,550 lawsuits involving Lipitor and diabetes have been centralized in South Carolina. The U.S. Judicial Panel on Multidistrict Litigation (JPML) centralized the litigation under Judge Richard M....
Number of Antibiotic Neuropathy Lawsuits Doubles to 200
September 17, 2015 — One month after a panel of federal judges centralized 78 lawsuits involving nerve damage (peripheral neuropathy) from fluoroquinolone antibiotics, the number of cases has doubled to nearly 200. In an update (PDF) from the judges, 192...
Re-Evaluation of Paxil Trial Finds It Unsafe for Teens
September 17, 2015 — A re-evaluation of a controversial clinical trial has concluded that Paxil is not safe for children and teenagers. After obtaining raw data from Study 329, investigators found that teenagers on Paxil did no better than a...
Takeda Inks $2.3 Billion Actos Settlement
Takeda Pharmaceuticals has agreed to a $2.3 billion settlement in over 10,000 Actos lawsuits.
Texas Serophene Class Action Lawyer
Recent studies have shown higher rates of many major birth defects in babies of women who used Serophene, a popular fertility drug, during or just before pregnancy. Need a Texas Serophene Lawyer? Collen A. Clark is a true advocate for...